Woodstock Corp’s Halozyme HALO Stock Holding History

Woodstock Corp’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-29,031	Closed	-$275K	–	156
2016 Q1	$275K	Hold	29,031	–	–	0.06%	133
2015 Q4	$503K	Buy	+29,031	New	+$463K	0.11%	107

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Woodstock Corp's HALO Position: Q2 2016 in Review

Woodstock Corp sold out of Halozyme (HALO) in Q2 2016, closing a stake of 29,031 shares — an estimated $275K sold.

Woodstock Corp first reported a position in HALO in Q4 2015 and held it in 2 quarters. The position peaked at $503K in Q4 2015. 161 funds tracked by Wall St. Rank hold HALO as of Q2 2016.

Woodstock Corp reported no remaining Halozyme position as of Q2 2016 after selling out during the quarter.
Woodstock Corp sold 29,031 Halozyme shares in Q2 2016, an estimated $275K.
Woodstock Corp first reported a position in Halozyme in Q4 2015 and held it in 2 quarters.
Woodstock Corp's Halozyme position peaked at $503K in Q4 2015.
161 funds tracked by Wall St. Rank held Halozyme as of Q2 2016.

Based on Woodstock Corp's 13F filing for Q2 2016, filed 3 Aug 2016.